• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide.

作者信息

Kenny A J, Stephenson S L

机构信息

Department of Biochemistry, University of Leeds, England.

出版信息

FEBS Lett. 1988 May 9;232(1):1-8. doi: 10.1016/0014-5793(88)80375-2.

DOI:10.1016/0014-5793(88)80375-2
PMID:2966745
Abstract

The circulating form of atrial natriuretic factor is a 28-residue peptide containing a 17-residue disulphide-linked ring. It has important actions on the kidney, largely on its haemodynamics, and at other sites including the adrenal cortex and CNS. It has a short half-life in vivo and is rapidly inactivated when incubated with kidney microvillar membranes. Of the battery of peptidases present in that membrane, only one, endopeptidase-24.11, is responsible for initiating the attack, and this commences with hydrolysis of the Cys7-Phe8 bond within the ring. Hydrolysis at this and other points has been shown to inactivate the peptide and this information has pointed the way to the synthesis of resistant analogues.

摘要

相似文献

1
Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide.
FEBS Lett. 1988 May 9;232(1):1-8. doi: 10.1016/0014-5793(88)80375-2.
2
A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium.一种被鉴定为中性内肽酶-24.11的94千道尔顿蛋白质,可使血管内皮中的心房利钠肽失活。
Mol Pharmacol. 1992 Apr;41(4):609-14.
3
The hydrolysis of brain and atrial natriuretic peptides by porcine choroid plexus is attributable to endopeptidase-24.11.猪脉络丛对脑钠肽和心钠肽的水解作用归因于内肽酶-24.11。
Biochem J. 1990 Oct 15;271(2):381-5. doi: 10.1042/bj2710381.
4
The hydrolysis of alpha-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11.猪肾微绒毛膜对α-人心房利钠肽的水解由内肽酶-24.11启动。
Biochem J. 1987 Apr 1;243(1):183-7. doi: 10.1042/bj2430183.
5
Hydrolysis of alpha-human atrial natriuretic peptide in vitro by human kidney membranes and purified endopeptidase-24.11. Evidence for a novel cleavage site.人肾膜和纯化的内肽酶-24.11在体外对α-人心房利钠肽的水解。一个新切割位点的证据。
Biochem J. 1988 Sep 1;254(2):531-7. doi: 10.1042/bj2540531.
6
Degradation and inactivation of rat atrial natriuretic peptide 1-28 by neutral endopeptidase-24.11 in rat pulmonary membranes.大鼠肺膜中中性内肽酶-24.11对大鼠心房利钠肽1-28的降解与失活作用
Regul Pept. 1992 Nov 20;42(1-2):85-96. doi: 10.1016/0167-0115(92)90026-q.
7
Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11.脑啡肽酶-24.11对人及猪脑钠肽、尿钠素、C型钠肽和一些C受体配体的水解作用
Biochem J. 1993 Apr 1;291 ( Pt 1)(Pt 1):83-8. doi: 10.1042/bj2910083.
8
The metabolism of neuropeptides. Hydrolysis of peptides by the phosphoramidon-insensitive rat kidney enzyme 'endopeptidase-2' and by rat microvillar membranes.神经肽的代谢。大鼠肾脏中对磷酰胺脒不敏感的“内肽酶-2”以及大鼠微绒毛膜对肽的水解作用。
Biochem J. 1988 Oct 1;255(1):45-51. doi: 10.1042/bj2550045.
9
Inactivation of atrial natriuretic factor by the renal brush border.肾刷状缘对心房利钠因子的灭活作用。
Biochim Biophys Acta. 1987 Jul 10;901(1):97-100. doi: 10.1016/0005-2736(87)90260-4.
10
Comparison of the hydrolysis of the three types of natriuretic peptides by human kidney neutral endopeptidase 24.11.人肾中性内肽酶24.11对三种利钠肽的水解作用比较
Biochem Mol Med. 1997 Jun;61(1):47-51. doi: 10.1006/bmme.1997.2584.

引用本文的文献

1
New and Emerging Therapeutic Drugs for the Treatment of Pulmonary Arterial Hypertension: A Systematic Review.用于治疗肺动脉高压的新型及新兴治疗药物:一项系统评价
Cureus. 2024 Aug 29;16(8):e68117. doi: 10.7759/cureus.68117. eCollection 2024 Aug.
2
Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A.太攀蛇降压肽是利钠肽受体 A 的有效且选择性激动剂。
Molecules. 2023 Mar 29;28(7):3063. doi: 10.3390/molecules28073063.
3
Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled, proof-of-concept trial.
奈普利肽抑制肺动脉高压:一项随机、双盲、安慰剂对照、概念验证试验。
Br J Pharmacol. 2019 May;176(9):1251-1267. doi: 10.1111/bph.14621. Epub 2019 Mar 31.
4
A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure.一项评估西地那非肽在慢性心力衰竭稳定期受试者中的安全性、耐受性和环磷酸鸟苷激活特性的人体研究。
Clin Pharmacol Ther. 2018 Sep;104(3):546-552. doi: 10.1002/cpt.974. Epub 2018 Jan 11.
5
Localization of corin and atrial natriuretic peptide expression in human renal segments.科林和心钠素在人肾段中的表达定位
Clin Sci (Lond). 2016 Sep 1;130(18):1655-64. doi: 10.1042/CS20160398. Epub 2016 Jun 24.
6
Immunolocalization of hyperpolarization-activated cationic HCN1 and HCN3 channels in the rat nephron: regulation of HCN3 by potassium diets.大鼠肾单位中超极化激活阳离子通道HCN1和HCN3的免疫定位:钾饮食对HCN3的调节
Histochem Cell Biol. 2016 Jan;145(1):25-40. doi: 10.1007/s00418-015-1375-6. Epub 2015 Oct 29.
7
Atrial natriuretic peptide in cardiovascular biology and disease (NPPA).心血管生物学与疾病中的心房利钠肽(NPPA)
Gene. 2015 Sep 10;569(1):1-6. doi: 10.1016/j.gene.2015.06.029. Epub 2015 Jun 12.
8
Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension.抑制磷酸二酯酶2可增强环鸟苷酸(cGMP)和环磷酸腺苷(cAMP)信号传导,以改善肺动脉高压。
Circulation. 2014 Aug 5;130(6):496-507. doi: 10.1161/CIRCULATIONAHA.114.009751. Epub 2014 Jun 4.
9
Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis.利钠肽在与肺纤维化相关的肺动脉高压中的内在防御能力和治疗潜力。
Br J Pharmacol. 2014 Jul;171(14):3463-75. doi: 10.1111/bph.12694.
10
A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions.一种人类心房利钠肽基因突变揭示了一种具有增强的降血压、增强肾脏功能和抑制醛固酮作用的新型肽。
J Am Coll Cardiol. 2009 Sep 8;54(11):1024-32. doi: 10.1016/j.jacc.2009.04.080.